Dachaigh › Aillse a' bhroilleach › New Jersey › Newark
Sgrùdaidhean clionaigeach Aillse a' bhroilleach ann an Newark, NJ
Tha 18 sgrùdaidhean airson Aillse a' bhroilleach a’ lorg phàirtichean aig làraichean ann agus timcheall air Newark (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.
Teacsa sgrùdaidh oifigeil (Beurla)
A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
A’ fastadhÌre 3
- Summit Health, Florham Park · 12 mìle air falbh
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
- Morristown Medical Center, Morristown · 17 mìle air falbh
A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
A’ fastadhÌre 2
- Medical Oncology Hematology Associates, Newark
A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer
A’ fastadhÌre 1/2
- Summit Medical Group, Florham Park · 12 mìle air falbh
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
A’ fastadhÌre 3
- Rutgers Cancer Institute of NJ (Rutgers, The State University of New Jersey), Newark
- Rutgers Cancer Institute of NJ (Rutgers, The State University of New Jersey), Livingston · 9 mìle air falbh
- Summit Medical Group PA, Florham Park · 12 mìle air falbh
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
A’ fastadhÌre 3
- Summit Medical Group, Florham Park · 12 mìle air falbh
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
A’ fastadhÌre 3
- Summit Medical Group, Florham Park · 12 mìle air falbh
Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies
A’ fastadhSgrùdadh amharc
- Summit Medical Group, Florham Park · 12 mìle air falbh
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
A’ fastadhÌre 3
- Newark Beth Israel Medical Center, Newark
- Cooperman Barnabas Medical Center, Livingston · 9 mìle air falbh
- Morristown Medical Center, Morristown · 17 mìle air falbh
A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study
A’ fastadhÌre 2
- GSK Investigational Site, Morristown · 17 mìle air falbh
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
A’ fastadhÌre 3
- Morristown Medical Center, Morristown · 17 mìle air falbh
SDM POSSIBLE: A Breast Cancer Treatment Decision Aid for Women 70+ With Low-Risk Stage I Breast Cancers
A’ fastadh
- Rutgers State University of New Jersey Medical School, Newark
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
A’ fastadhSgrùdadh amharc
- Morristown Medical Center, Morristown · 17 mìle air falbh
Confirmatory Clinical Evaluation of Novilase® Laser Therapy for Focal Destruction of Malignant Breast Tumors
A’ fastadh
- Summit Health, Florham Park · 12 mìle air falbh
RADIANT: Pre-op Radiation With Abemaciclib and Letrozole
A’ fastadhÌre 1
- RWJBarnabas Health Clara Maas Medical Center, Belleville · 4 mìle air falbh
- Cooperman Barnabas Medical Center, Livingston · 9 mìle air falbh
Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted
A’ fastadhÌre 2
- RWJBarnabas Health - Newark Beth Israel Medical Center, Newark
DPYD Pharmacogenomics and Fluoropyrimidine (FP) Dose-Adjustment
A’ fastadhÌre 4
- Cancer Center Initiative, Newark
- University Hospital, Newark
- RWJBarnabas Health Newark Beth Israel Medical Center, Newark
- agus 2 a bharrachd
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
A’ fastadhÌre 3
- Morristown Medical Center, Morristown · 17 mìle air falbh
Sgrùdaidhean Aillse a' bhroilleach ann am bailtean eile
- New York City, NY136 sgrùdaidhean
- Houston, TX126 sgrùdaidhean
- Boston, MA112 sgrùdaidhean
- Nashville, TN81 sgrùdaidhean
- Los Angeles, CA73 sgrùdaidhean
- Edison, NJ68 sgrùdaidhean
- St. Louis, MO64 sgrùdaidhean
- Queens, NY64 sgrùdaidhean
- Durham, NC64 sgrùdaidhean
- Chicago, IL59 sgrùdaidhean
- Philadelphia, PA56 sgrùdaidhean
- Dallas, TX55 sgrùdaidhean
Sgrùdaidhean eile ann an Newark
- Leòintean an Chòrd Droma13 sgrùdaidhean
- Aillse Sgamhain Neo-chealla-beag13 sgrùdaidhean
- Leukemia myeloid geur12 sgrùdaidhean
- Fàilligeadh a' Chridhe10 sgrùdaidhean
- Ailse metastatach10 sgrùdaidhean
- Galarachd Cardiovasculach9 sgrùdaidhean
- Cancer Pancreatic9 sgrùdaidhean
- Melanoma8 sgrùdaidhean
- Aillse (gach seòrsa)7 sgrùdaidhean
- Ailseachadh nan Sgamhan7 sgrùdaidhean
- Galar Crohn7 sgrùdaidhean
- Stenosis bhalbh aortic6 sgrùdaidhean
Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.